Validation of different personalized risk models of chemotherapy‐induced nausea and vomiting: results of a randomized, double‐blind, phase III trial of fosaprepitant for cancer patients treated with high‐dose cisplatin

Author:

Zhao Yuanyuan1ORCID,Zhao Bing2,Chen Gang1,Chen Yinlan3,Liao Zijun4,Zhang Haiming5,Feng Weineng6,Li Yinyin7,Weng Heng8,Li Weidong9,Zhou Yuefen10,Ren Biyong11,Lu Yanda12,Chen Jianhua13,Liu Zhenteng14,Su Zhenzhong14,Wang Wenliang14,Zhang Li1

Affiliation:

1. Department of Medical Oncology Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangzhou Guangdong P. R. China

2. Department of Day Ward First Affiliated Hospital of Xinjiang Medical University Urumqi Xinjiang P. R. China

3. Department of Medical Oncology Jiangxi Cancer Hospital Nanchang Jiangxi P. R. China

4. Department of Medical Oncology Shaanxi Provincial Cancer Hospital Xi'an Shaanxi P. R. China

5. Department of Medical Oncology The First People Hospital of Xiangtan Xiangtan Hunan P. R. China

6. Department of Medical Oncology The First People Hospital of Foshan Foshan Guangdong P. R. China

7. Department of Medical Oncology Shenyang Tenth People's Hospital Shenyang Liaoning P. R. China

8. Respiratory Medicine Fuzhou Pulmonary Hospital of Fujian Fuzhou Fujian P. R. China

9. Department of Medical Oncology Affiliated Cancer Hospital & Institute of Guangzhou Medical University Guangzhou Guangdong P. R. China

10. Department of Medical Oncology The Central Hospital of Lishui Lishui Zhejiang P. R. China

11. Department of Medical Oncology Chongqing Three Gorges Central Hospital Chongqing P. R. China

12. Department of Medical Oncology The First Affiliated Hospital of Hainan Medical University Haikou Hainan P. R. China

13. Department of Medical Oncology Hunan Province Tumor Hospital Changsha Hunan P. R. China

14. Institute of Materia Medica Luoxin Pharmaceutical Group Co., Ltd Shanghai P. R. China

Publisher

Wiley

Subject

Cancer Research,Oncology

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3